EA200602049A1 - Пролекарства стероидов с андрогенным действием - Google Patents

Пролекарства стероидов с андрогенным действием

Info

Publication number
EA200602049A1
EA200602049A1 EA200602049A EA200602049A EA200602049A1 EA 200602049 A1 EA200602049 A1 EA 200602049A1 EA 200602049 A EA200602049 A EA 200602049A EA 200602049 A EA200602049 A EA 200602049A EA 200602049 A1 EA200602049 A1 EA 200602049A1
Authority
EA
Eurasian Patent Office
Prior art keywords
steroids
procedures
androgenic action
androgenic
action
Prior art date
Application number
EA200602049A
Other languages
English (en)
Russian (ru)
Inventor
Ральф Вырва
Петер Дрёшер
Свен Ринг
Вальтер Эльгер
Биргитт Шнайдер
Александер Хиллиш
Гудрун Реддерсен
Original Assignee
Шеринг Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг Акциенгезельшафт filed Critical Шеринг Акциенгезельшафт
Publication of EA200602049A1 publication Critical patent/EA200602049A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EA200602049A 2004-05-21 2005-05-10 Пролекарства стероидов с андрогенным действием EA200602049A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung
PCT/EP2005/005256 WO2005113575A1 (de) 2004-05-21 2005-05-10 Steroid-prodrugs mit androgener wirkung

Publications (1)

Publication Number Publication Date
EA200602049A1 true EA200602049A1 (ru) 2007-06-29

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602049A EA200602049A1 (ru) 2004-05-21 2005-05-10 Пролекарства стероидов с андрогенным действием

Country Status (22)

Country Link
EP (1) EP1747229A1 (es)
JP (1) JP2007538026A (es)
CN (1) CN1993375A (es)
AR (1) AR049547A1 (es)
AU (1) AU2005245568A1 (es)
BR (1) BRPI0510136A (es)
CA (1) CA2564963A1 (es)
CR (1) CR8785A (es)
DE (1) DE102004025986A1 (es)
EA (1) EA200602049A1 (es)
EC (1) ECSP067028A (es)
GT (1) GT200500122A (es)
IL (1) IL179293A0 (es)
MX (1) MXPA06013469A (es)
NO (1) NO20065885L (es)
PA (1) PA8633601A1 (es)
PE (1) PE20060271A1 (es)
SV (1) SV2006002123A (es)
TW (1) TW200613317A (es)
UY (1) UY28911A1 (es)
WO (1) WO2005113575A1 (es)
ZA (1) ZA200610769B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
WO2005113575A1 (de) 2005-12-01
GT200500122A (es) 2006-01-24
CA2564963A1 (en) 2005-12-01
IL179293A0 (en) 2007-03-08
SV2006002123A (es) 2006-02-15
BRPI0510136A (pt) 2007-10-02
JP2007538026A (ja) 2007-12-27
CN1993375A (zh) 2007-07-04
AU2005245568A1 (en) 2005-12-01
PE20060271A1 (es) 2006-05-25
UY28911A1 (es) 2005-12-30
DE102004025986A1 (de) 2005-12-15
NO20065885L (no) 2006-12-19
CR8785A (es) 2007-02-05
EP1747229A1 (de) 2007-01-31
ECSP067028A (es) 2006-12-29
PA8633601A1 (es) 2006-07-03
AR049547A1 (es) 2006-08-16
TW200613317A (en) 2006-05-01
ZA200610769B (en) 2008-08-27
MXPA06013469A (es) 2007-01-23

Similar Documents

Publication Publication Date Title
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
UY32648A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA200971074A1 (ru) Антивирусные соединения
EA200971078A1 (ru) Противовирусные соединения
UA109667C2 (xx) Похідні хіназолін-4(3h)-ону, що використовуються як інгібітори pi3-кінази
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
EA201100503A1 (ru) Глюкозидные производные и их применения
CR20140071A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
UY31065A1 (es) Heterociclos ciclicos
EA200602049A1 (ru) Пролекарства стероидов с андрогенным действием
EA201000436A1 (ru) Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA200971140A1 (ru) Триарильные соединения и композиции, их содержащие
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
SG158091A1 (en) Imidazoazepinone compounds
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
MA32945B1 (fr) Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique